Evidence map›Paper›PMID 31011303›Full record

ArticleGastroenterology & hepatology2019

Management Approaches to Hepatitis B Virus Vaccination Nonresponse.

Beshoy Yanny, Peter Konyn, Lisa M Najarian, Amanda Mitry, Sammy Saab

Registry-linked trialAbstract read
PubMed Full text at PMC
In one paragraph

Article in Gastroenterology & hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04588077 (Comparison the Seroconversion Rate Between Two-dose and Three-dose Regimens of Heplisav B Among Patients With Cirrhosis, a Randomized-control Prospective Study.), which is not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04588077 phase4recruitingnot on this mapstarted 2020, after this paper: background citation

Comparison the Seroconversion Rate Between Two-dose and Three-dose Regimens of Heplisav B Among Patients With Cirrhosis, a Randomized-control Prospective Study.

TypeinterventionalSponsorMercy Medical CenterRan2020 to 2028Enrolled200ConditionsHepatitis B, Cirrhosis, Liver, Chronic Liver DiseaseArmsHeplisav-B Injectable Product, 2-dose regimen, Heplisav-B Injectable Product, 3-dose regimen
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Review
  3. Article
  4. Diagnosis and management of celiac disease.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Successful response of intradermal hepatitis B vaccine in nonresponders of intramuscular hepatitis B vaccine in general and hemodialysis population.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2020
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Beshoy YannyDr Yanny is a health science clinical instructor of medicine and Mr Konyn is a medical student in the Department of Medicine at the University of California at Los Angeles in Los Angeles, California. Ms Najarian is a premedical student in the Department of Surgery at the University of California at Los Angeles. Ms Mitry is a graduate student at Claremont Graduate University in Riverside, California.
Peter KonynDr Yanny is a health science clinical instructor of medicine and Mr Konyn is a medical student in the Department of Medicine at the University of California at Los Angeles in Los Angeles, California. Ms Najarian is a premedical student in the Department of Surgery at the University of California at Los Angeles. Ms Mitry is a graduate student at Claremont Graduate University in Riverside, California.
Lisa M NajarianDr Yanny is a health science clinical instructor of medicine and Mr Konyn is a medical student in the Department of Medicine at the University of California at Los Angeles in Los Angeles, California. Ms Najarian is a premedical student in the Department of Surgery at the University of California at Los Angeles. Ms Mitry is a graduate student at Claremont Graduate University in Riverside, California.
Amanda MitryDr Yanny is a health science clinical instructor of medicine and Mr Konyn is a medical student in the Department of Medicine at the University of California at Los Angeles in Los Angeles, California. Ms Najarian is a premedical student in the Department of Surgery at the University of California at Los Angeles. Ms Mitry is a graduate student at Claremont Graduate University in Riverside, California.
Sammy SaabDr Yanny is a health science clinical instructor of medicine and Mr Konyn is a medical student in the Department of Medicine at the University of California at Los Angeles in Los Angeles, California. Ms Najarian is a premedical student in the Department of Surgery at the University of California at Los Angeles. Ms Mitry is a graduate student at Claremont Graduate University in Riverside, California.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis B virus vaccinehepatitis immunityimmunologic response

Identifiers

PMID31011303
PMCPMC6469266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.